ATOSSA THERAPEUTICS, INC. (ATOS) Free cash flow 2018–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.8MFY2025 · since FY2018: -$9.1M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | -41.5% |
| FY2024 | -$21.0M | -0.4% |
| FY2023 | -$21.0M | -0.8% |
| FY2022 | -$20.8M | -26.1% |
| FY2021 | -$16.5M | -42.3% |
| FY2020 | -$11.6M | -26.7% |
| FY2019 | -$9.1M | -0.7% |
| FY2018 | -$9.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice